Mechanistic safety assessment via multi-omic characterisation of systemic pathway perturbations following in vivo MAT2A inhibition.
Fogal V, Michopoulos F, Jarnuczak AF, Hamza GM, Harlfinger S, Davey P, Hulme H, Atkinson SJ, Gabrowski P, Cheung T, Grondine M, Hoover C, Rose J, Bray C, Foster AJ, Askin S, Majumder MM, Fitzpatrick P, Miele E, Macdonald R, Keun HC, Coen M.
Fogal V, et al. Among authors: hoover c.
Arch Toxicol. 2024 May 17. doi: 10.1007/s00204-024-03771-w. Online ahead of print.
Arch Toxicol. 2024.
PMID: 38755480